Personalized Tumor Vaccines and Pabolizumab in Patients With Advanced Pancreatic Cancer
Personalized Tumor Vaccines and Pabolizumab in Patients With Advanced Pancreatic Cancer
Recruiting · NCT05916261 · Registry updated 2023-10-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Personalized Tumor Vaccines and Pabolizumab in Patients With Advanced Pancreatic Cancer | Advanced Pancreatic Cancer | Recruiting | Early phase 1 | 2023-10-26 | NCT05916261 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ruijin Hospital | 454 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Ruijin-Hainan Hospital Affiliated to Shanghai Jiao Tong University School of Medicine | Qionghai | China | 1 |